China Biotech Services Holdings (HKSE:08037) Net Margin % : -261.43% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. China Biotech Services Holdings's Net Income for the three months ended in Dec. 2023 was HK$-29.5 Mil. China Biotech Services Holdings's Revenue for the three months ended in Dec. 2023 was HK$11.3 Mil. Therefore, China Biotech Services Holdings's net margin for the quarter that ended in Dec. 2023 was -261.43%.

The historical rank and industry rank for China Biotech Services Holdings's Net Margin % or its related term are showing as below:

HKSE:08037' s Net Margin % Range Over the Past 10 Years
Min: -182.46 Med: -58.94 Max: 13.94
Current: -45.03

HKSE:08037's Net Margin % is ranked worse than
63.76% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.535 vs HKSE:08037: -45.03

China Biotech Services Holdings Net Margin % Historical Data

The historical data trend for China Biotech Services Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Biotech Services Holdings Net Margin % Chart

China Biotech Services Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-166.93

4.60

3.11

13.94

-45.03

China Biotech Services Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															17.12	-11.78	-29.17	-193.36	-261.43

Competitive Comparison of China Biotech Services Holdings's Net Margin %

For the Diagnostics & Research subindustry, China Biotech Services Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Biotech Services Holdings's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where China Biotech Services Holdings's Net Margin % falls into.

China Biotech Services Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

China Biotech Services Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-95.447	/	211.985
	=	-45.03 %

China Biotech Services Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-29.471	/	11.273
	=	-261.43 %

China Biotech Services Holdings (HKSE:08037) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

China Biotech Services Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Biotech Services Holdings (HKSE:08037) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG

Website

http://www.cbshhk.com

China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.

Executives

Liu Xiaolin	2101 Beneficial owner
Genius Earn Limited	2201 Interest of corporation controlled by you
Genius Lead Limited	2101 Beneficial owner
Guoyuan International Holdings Limited	2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd.	2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited	2101 Beneficial owner
Richlane Ventures Limited	2101 Beneficial owner
Ko Chun Shun, Johnson	2201 Interest of corporation controlled by you

China Biotech Services Holdings (HKSE:08037) Headlines

No Headlines